First safety check for new migraine drug combo
NCT ID NCT06578585
Summary
This study tested the safety of a new migraine injection (Lu AG09222) when taken with an existing oral migraine medication (ubrogepant). It involved 43 adults with a history of migraine to see if the combination caused any new or worsening side effects. This was an early-stage trial focused primarily on safety and how the drugs interact in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Neuroscience Solutions
Orlando, Florida, 32801, United States
-
Elevate Clinical Research
Seabrook, Texas, 77586, United States
-
Future Search Trials
Austin, Texas, 78731, United States
-
NeuroTrials Research
Atlanta, Georgia, 30328, United States
Conditions
Explore the condition pages connected to this study.